-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Protagenic Therapeutics, Inc.\new quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Mar 2016 to 30 Jun 2025.
- Protagenic Therapeutics, Inc.\new Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Jun 2025 was $4,422,960, a 359% increase year-over-year.
- Protagenic Therapeutics, Inc.\new annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,963,546.
- Protagenic Therapeutics, Inc.\new annual Net Cash Provided by (Used in) Financing Activities for 2021 was $12,577,664, a 928% increase from 2020.
- Protagenic Therapeutics, Inc.\new annual Net Cash Provided by (Used in) Financing Activities for 2020 was $1,223,410, a 83% increase from 2019.